SCHNEIDER EUGENE (EVP, Chf Clinical Develop Offc) sold 25.2% of their position (26K shares) of IONIS PHARMACEUTICALS INC on the open market
Open‑market sale worth $2.11M — a significant reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 6/30/2026ACC: 0000874015-26-000216
Officer· EVP, Chf Clinical Develop Offc
Since Dec 2020
-26K
Net shares
Net seller
$2.11M
Total sold
1
Open market trades
0B · 1S
3
Total transactions
26K acquired · 52K disposed
Non-Derivative Transactions2
Common Stock
Direct
Shares
+26K
Price / share
$60.89
Trade value
$1.58M
% of position
33.7%
6/26/2026
77.11K→103.11K
Common Stock
Direct
Shares
−26K
Price / share
$81.05
Trade value
$2.11M
% of position
25.2%
6/26/2026
103.11K→77.11K
Total
Net shares
+0.00
Net value
-$524.06K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 6/26/2026 | M · Option Exercise | +26K | $60.89 | $1.58M | 33.7% | 77.11K | 103.11K |
| Common Stock Direct | 6/26/2026 | S · Sale | −26K | $81.05 | $2.11M | 25.2% | 103.11K | 77.11K |
| Total | +0.00 | -$524.06K | ||||||
Derivative Transactions1
Non-Qualified Stock Option (right to buy)
Direct
Converts to
Common Stock
26K shares
Shares
−26K
Strike price
60.89
Held after
26K
Exercisable
—
6/26/2026
| Security | Converts To | Date | Type | Shares | Strike Price | Exercisable | Held After |
|---|---|---|---|---|---|---|---|
| Non-Qualified Stock Option (right to buy) Direct | Common Stock26K shares | 6/26/2026 | M · Option Exercise | −26K | 60.89 | — | 26K |